Variation in EGF/Ras signaling in C. elegans and C. briggsae vulval development by Zitnik, Edward
Variation in EGF/Ras signaling in C. elegans and C. briggsae vulval development 
 
 
Honors Research Thesis 
 
 
Presented in Partial Fulfillment of the Requirements for graduation 
“with Honors Research Distinction in Molecular Genetics” in the undergraduate 




Edward M. Zitnik, Jr. 
 
 








- 1 - 
 
Abstract 
 The EGF/Ras signal transduction pathway has been shown to be essential in nematode 
vulval development. When levels of EGF signal are manipulated, precursor cells that give rise to 
the adult vulva (egg-laying structure) have different division patterns. When EGF/Ras is 
overactive, the precursor cells experience extra divisions. These extra cellular divisions model 
tumor growth. Individuals in the human population have varying sensitivities to mutations in this 
pathway and modern chemotherapy treatments attempt to individualize treatment to account for 
these differences. To further model this variance, we examine the vulva development system in 
two species of nematode, C. elegans and C. briggsae. Like two patients both presenting with 
tumors, these two species both develop extra cellular divisions from hyperactive EGF/Ras 
signaling, yet they react differently when treated with drug therapies. I have completed three 
experiments which show the variation across the two species to U0126, a small molecule 
inhibitor of mitogen-activated protein kinase kinase (MEK), which acts in the EGF/Ras pathway. 
The first is a dose response experiment on wild-type animals which shows a complete 
elimination of vulva development in C. elegans but only a partial reduction in development in C. 
briggsae. The second is a drug treatment of nematodes with an extra cell division phenotype 
which shows elimination of the phenotype in C. elegans and a reduced—yet still present—
proportion of animals expressing the phenotype in C. briggsae. The third experiment exposes the 
mutant sur-2, a downstream component of the EGF/Ras pathway, to the inhibitor and shows 
complete elimination of precursor cell division in C. elegans, and only a marginal decrease in 
division in C. briggsae. The results of these three experiments suggest that the vulval 
development process in C. briggsae is less sensitive to EGF signaling than in C. elegans and C. 
briggsae may rely on alternative signaling sources to develop the vulval tissue. 
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Introduction 
 The EGF/Ras signal transduction pathway plays important roles in cancer development, 
and individuals in the population have varying sensitivities to mutations in this pathway 
(Johnson, 2014). By understanding the underlying molecular basis for cancer development, 
physicians can alter chemotherapy treatments to fit the unique genetic needs of the patient by 
altering dosage and targets. This process is still not well understood at such an early point in the 
field, and thus we need to use model systems for preliminary findings. Studying the vulva 
development system in two species of nematodes allows us to compare the genetic networks 
between two species and evaluate the evolution of these networks. Using a model system allows 
us to manipulate these pathways and develop synthetic mutants. The nematode vulva system is a 
suitable candidate to answer this research question as there is evidence of a common biological 
outcome (vulva development) with varying underlying genetic networks between the two species 
(Felix, 2007). 
 In signal transduction networks, cells communicate to one another to promote 
development and spatial patterning. When one cell releases a signaling molecule, often termed a 
ligand, a neighboring cell receives the signal with a receptor on its surface. This interaction 
triggers a series of biological events that results in a certain set of genes being turned on within 
the cell, resulting in a specific physiological response. The nematode egg-laying structure (vulva) 
develops using several of these networks, including EGF, Wnt, and DSL/Notch. (Yoo, 2004). 
This thesis focuses on EGF. 
 The C. elegans vulva is comprised of six vulva precursor cells (VPC) located on the 
ventral surface of the worm. A seventh cell, termed the anchor cell, is dorsal to the vulva 
precursor cells which divide during development into 22 mature vulval cells. The anchor cell 
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releases the Epidermal Growth Factor (EGF) ligand where it is subsequently received by the 
VPCs and influences their cell division 
(Sommer, 2012). Due to the increased 
distance between the anchor cell and each 
individual VPC, the cells receive varying 
amounts of the EGF ligand and develop into 
different patterns. The cell located closest to 
the anchor cell, P6.p, develops into the 
primary (1
o
) cell fate, while the two adjacent 
cells, P5.p and P7.p, develop into the secondary (2
o
) cell fate. Located even further from the 
anchor cell are the un-induced cells, P3.p, P4.p and P8.p, which adopt the tertiary (3
o
) cell fate, 
divide one time and fuse to the hypodermis. Figure 1 shows the patterning of a wild-type vulva 
(Green, 2007).  
 Two mutant vulval phenotypes discussed in this work are the multivulval (Muv) and 
vulvaless (Vul). In Muv mutants more vulval precursor cells divide than expected which results 
in multiple pseudo-vulvae on the ventral surface of the animal. These additional vulvae appear as 
tumor-like protrusions. The Muv phenotype can be attained when the EGF pathway is 
hyperactive, causing additional VPCs to divide. In Vul mutants and other mutants with 
patterning defects, fewer vulval precursor cells divide than expected or the same number of cells 
divide but take on a lower cell fate (i.e., P6.p attains a 2
o
 cell fate rather than a 1
o
 cell fate). This 
phenotype can be attained when the EGF pathway is compromised, thus producing less of the 
EGF ligand to be received by VPCs. This causes them to either remain undivided or to take on a 
lower cell fate. The wild type, Muv, and Vul mutants are illustrated in Figure 2. Examining 
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these mutants in relation to wild type animals informs our understanding of which signaling 
pathways are involved in vulval development and to what extent they regulate cell fate decisions. 
 The egg-laying structure of the nematode worm species Caenorhabditis elegans and 
Caenorhabditis briggsae is an appropriate 
model for studying tissue development. The 
preliminary data suggest that there is one of 
two biological phenomena occurring in C. 
briggsae and C. elegans vulval 
development: the C. briggsae developmental 
network is more robust to EGF pathway 
disruptions, or there is an alternative 
signaling source that is EGF/Ras-
independent involved in C. briggsae 
vulval development. Both questions are 
pursued  in this body of work to uncover pathway flexibilities that might also parallel the 
variation of individuals in a human population. 
 
Materials and Methods 
Strains 
 The Multivulval mutants and the sur-2 mutant used in these experiments were generated 
from a genetic screen using Ethyl Methane Sulfonate (EMS). The strains Cbr-lin-1(gu198), Cbr-
lin-31(gu138), Cbr-lin31(gu162), Cbr-pry-1(gu137), Cbr-lin(gu102), Cbr-lin(gu163), Cbr-
lin(gu167), Cbr-sur-2(gu185), and Cbr-lin(gu168) were generated from a genetic screen in the 
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lab of Dr. Helen Chamberlin. Cbr-lin-31(sy5342), Cbr-lin-31(sy5344), Cbr-pry-1(sy5353), Cbr-
pry-1(sy5411), Cbr-pry-1(sy5270), and Cbr-lin(sy5216) were generated from the genetic screen 
in the lab of Dr. Gupta in collaboration with other work between the Chamberlin and Gupta labs. 
Cbr-lin-1(sa993), Cbr(bh9), Cel-let-60(n1046), and Cel-sur-2(ku9) were alleles requested from 
other labs also researching nematode vulval development. The C. elegans and C. briggsae wild 
type strains used were N2 and AF16 respectively. 
U0126 assay 
 C. briggsae and C. elegans animals were treated with the MEK inhibitor U0126 
(technical data shown in Figure 3) using a plate assay, following a general protocol (Reiner et al, 
2008). A stock of a 10 mM U0126 solution in DMSO (Dimethyl Sulfoxide) was diluted with 1X 
M9, with 150 ul of the solution spread on NGM (Nematode Growth Medium) plates (5 ml NGM 
in 35 mm petri plates).  The solution was 
allowed to absorb into the agar overnight at 
room temperature, with final concentration of 
drug calculated for the whole plate volume.  
Three drops of OP50 E. coli were added to the 
center of each plate on day two, and allowed to 
dry overnight at room temperature.  On day three, approximately 20 L1 worms were added to 
each plate.  All plates were then moved to 20°C.  When specific vulval precursor cell fates were 
determined using cell lineage markers under high magnification, L4 animals were scored two 
days after originally being plated. When the Muv phenotype was being scored, adult worms were 
scored for presence of extra ventral protrusions after three days. 
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Microscopy 
 Animals were scored using both a dissection microscope and a compound microscope 
with Nomarski to view phenotypes on both the whole-animal and cellular level. When data were 
collected from animals to determine the proportion of animals who exhibited the Muv 
phenotype, the dissection microscope was used. Each animal was placed into three categories 
based on the number of sites on the ventral surface of the worm that had protruding vulval cells, 
those being zero, one, and greater than one protrusion. When the data were represented in the 
figures, the one and greater than one protrusion categories were combined and scored as Muv. 
The zero protrusion category was scored as non-Muv. This was viewed at plate-level in adult 
animals. 
 When data were collected from animals to determine the number of vulval precursor cells 
(VPCs) that divided, the Nomarski compound microscope was used. Mid-L4 animals were 
mounted on agar pads with 10 mM Sodium Azide anesthetic and viewed at high magnification. 
The number of divided VPCs was determined by analyzing the tissue morphology under DIC 
and the egl-17::GFP secondary cell lineage marker. Epifluorescence was visualized using GFP 
filters on the Nomarski compound microscope. 
 
Results 
C. briggsae multivulval mutants exhibit varying sensitivities to EGF signal disruption and are 
less sensitive to pathway interference than C. elegans 
 The multivulval mutant results from a hyperactivated EGF pathway. Both species 
provided a reliable pool of Muv mutants upon treatment with EMS, which were treated with the 
U0126 MEK inhibitor. MEK acts in the EGF pathway within vulval precursor cells and is shown 
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in Figure 4. This drug has proven to work in worm species previously (Reiner et al, 2008; 
Dichtel-Danjoy, 2004). Fourteen lines were 
generated from the EMS mutagenesis screen. 
One line from each complementation group was 
tested using the U0126 inhibitor. Cbr-lin-1 was 
tested using the inhibitor as a negative control 
because of its predicted position in the pathway. 
Figure 5 shows the proportion of animals who 
confer the Muv phenotype when exposed to 0 
uM, 10 uM, and 30 uM U0126 during larval 
stage development. While Cbr-lin-1(gu198) shows no difference between the experimental and 
control group, all of the other Muv mutants show a decrease in Muv proportion as the dose of the 
U0126 inhibitor increases. This result suggests that the Muv phenotype in these C. briggsae 
mutants is Mek-dependent. 
 To compare the 
sensitivity of MEK inhibition 
in C. briggsae to the 
sensitivity in C. elegans, the 
U0126 inhibitor was tested on 
the C. elegans Muv mutant 
Cel-let-60(n1046). let-60 
encodes the Ras protein and 
acts in the EGF pathway 
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downstream of the let-23 EGF Receptor (EGFR) and upstream of MEK. This mutant makes Ras 
constitutively active. Due to its predicted position in the pathway, let-60 is expected to be 
affected by MEK inhibition. Figure 6 
shows the results of testing the 
inhibitor on the C. elegans Muv 
mutant and Cbr-lin(gu167), which is 
representative of the C. briggsae Muv 
mutant pool. The Cbr-lin(gu167) line 
was chosen because it showed the 
most sensitive reaction to the 
inhibitor. In the assay, the C. elegans mutant showed an elimination of the Muv phenotype at the 
10 uM concentration while the C. briggsae mutant retained the phenotype. This result suggests 
that EGF signaling is important for vulval development in both C. elegans and C. briggsae, but 
may regulate the system less strictly in C. briggsae than in C. elegans. 
 
C. briggsae show a lower sensitivity to EGF perturbation than C. elegans in an unstressed 
system 
 To test the effect of U0126 on C. elegans and C. briggsae in the absence of other pathway 
perturbations, the MEK inhibitor was also tested on genetically wild type animals. Since these 
animals do not exhibit the Muv phenotype, they were assayed for the number of vulval precursor 
cells which divide upon treatment with the inhibitor drug by examining the cell morphology 
under high magnification. In a wild type animal three VPCs divide (P5.p, P6.p, and P7.p). Any 
level of division greater than the 3
o
 cell fate is called induction. In the example of a wild type 
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animal, three cells are said to be induced. The data from the wild-type assay are shown in Figure 
7. The C. elegans animals displayed eliminated induction at 100 uM U0126. C. briggsae animals 
displayed a reduction, but VPC 
induction is never eliminated. 
Doses higher than 100 uM were 
tested, but no animals survived as 
adults (data not shown). 
 Phenotypic data was also 
collected from the U0126 wild 
type assay and animals were 
scored for presence of the egl-
17::GFP secondary cell lineage marker. In an untreated wild type animal this marker expresses 
in the P5.p and P7.p which lie adjacent to the primary cell. Representative images from the assay 
are shown in Figure 8. Untreated wild 
type animals consistently expressed vulC 
and vulD cells (secondary cell lineage) in 
the P5.p and P7.p. Wild type C. briggsae 
animals treated with 30 uM U0126, 
which had an average of less than two 
VPCs dividing, expressed the GFP-
positive vector in vulC cells in the P6.p. 
The P6.p traditionally confers the primary 
cell fate and would not express this reporter. 
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Both C. briggsae and C. elegans sur-2 mutants show a loss of the primary cell fate with EGF 
perturbation and C. briggsae show a lower sensitivity to the inhibition 
 The first prediction that the C. 
briggsae developmental network is 
more robust to EGF pathway 
disruptions was tested by examining 
the synergistic effect of sur-2 mutants 
treated with U0126. The gene Cel-
sur-2 acts in the EGF/Ras pathway to 
regulate transcription of vulva 
development genes downstream of 
let-60 Ras and encodes a member of the mediator complex protein MED-23. The mediator 
complex assembles with RNA polymerase II to regulate transcription of genes important in 
vulval development (Singh, 1995). When mutated in C. elegans, it suppresses the effect of 
activated Ras protein, thus reducing EGF/Ras signaling by binding a mutant SUR-2 protein with 
wild-type components of MED-23. This results in a non-functional mediator complex. Since this 
gene plays an important role in C. elegans vulva development (Singh, 1995), it is a suitable 
candidate for experimentation in C. briggsae. In these experiments, the Cbr-sur-2 mutant 
(gu185) showed a decrease in proportion of animals taking on a 1
o
 cell fate in the P6.p VPC. 
Phenotypic data are shown in Figure 9 which reveals untreated C.br-sur-2 mutants express the 
egl-17::GFP secondary cell lineage marker in the P5.p, P6.p, and P7.p, thus losing primary cell 
identity in the P6.p. 
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 Since U0126 also disrupts the EGF/Ras signaling pathway at a different target than sur-2, 
coupling its effects with the mutant is predicted to enhance the phenotype, thus confirming the 
primary role of EGF/Ras in vulva 
development. Both Cel-sur-2(ku9) and 
Cbr-sur-2(gu185) were treated with 
U0126 and scored for number of VPCs 
dividing when the cell morphology was 
viewed under high magnification. As 
shown in Figure 10, induction was 
eliminated in C. elegans and maintained in C. briggsae upon treatment with U0126, yet the 
coupled effect of the MEK inhibitor and the mutant line did not display a significant synergistic 
effect. 
  
Alternative signaling pathways were tested to identify the source of differences in EGF 
suppression seen between C. elegans and C. briggsae 
 To test the second prediction that there is an alternative signaling source that is EGF/Ras-
independent involved in C. briggsae vulval development, additional signaling sources were 
tested. Among the candidates were Wnt and Notch. Wnt has been previously understood to 
sensitize VPCs to EGF signaling and Notch is known to function in lateral inhibition of EGF 
signaling. One of these signaling sources may serve as the explanation of the differences in 
vulval induction between C. elegans and C. briggsae. A vector was created with a truncated form 
of Cbr-cam-1 which lacks the transmembrane domain driven by a myo-3 promoter. cam-1 
encodes a receptor tyrosine kinase which co-localizes with lin-17 to form the frizzled receptor in 
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the Wnt signaling pathway on the surface of VPCs. Because the ligand-binding domain is still 
expressed, this reporter is predicted to sequester Wnt ligands by expressing in the muscle cells 
surrounding the VPCs and reduces Wnt signaling in the developing vulval tissue (Green, 2007). 
Lines produced from this reporter showed no observable phenotype in the vulva or gonad and 
also showed no observable 
synergistic effect when coupled 
with the U0126 inhibitor. While 
this negative result is not 
conclusive, the VPCs were still 
primed and able to divide. A 
second vector was created which promotes the transcription of a truncated form of sel-8/MAM 
upon activation of a heatshock promoter. The SEL-8 protein binds to and stabilizes the DNA-
binding complex of the intracellular domains of Notch DNA-binding proteins in the nucleus 
(Oyama, 2007). This gene serves 
as a way to reduce Notch 
signaling within vulval precursor 
cells by eliminating the domain 
responsible for recruiting kinase 
and co-activator domains. The 
truncated form of the protein creates protein complexes which assemble with other wild-type 
domains but do not produce a functional protein complex. The table in Figure 11 displays a low 
frequency phenomenon where two adjacent VPCs confer a primary cell fate, rather than a 
primary cell flanked by two secondary cells. A representative image is shown in Figure 12. This 
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supports the role in promoting the 2
o
 cell fate which Notch is understood to play based on 
previous work.  
 
Discussion 
 Vulval development was measured in three settings where the EGF pathway was 
hyperactived, unstressed, or compromised. Both wild type and U0126-treated animals were 
scored in the assays. Across these assays, there were four main conclusions:  
 1) Vulval development can be eliminated in C. elegans upon treatment with an EGF 
pathway inhibitor. When the Cel-let-60 mutant was treated with the inhibitor the Muv phenotype 
was completely eliminated upon increasing the dose of U0126. In the unstressed wild type assay 
this result was replicated with vulval induction being completely eliminated with the 100 uM 
U0126 treatment. In the EGF compromised assay C.el-sur-2 had a basal level of lower induction 
than wild type C. elegans and treatment with U0126 was still able to fully eliminate induction. 
Collectively, these three assays confirm the dominating role EGF plays in promoting vulval 
induction in C. elegans. Without EGF present, this species is unable to develop the vulva. 
 2) Vulval induction is only partially eliminated in C. briggsae upon treatment with same 
EGF pathway inhibitor. In the hyperactivated EGF animals the Muv phenotype was maintained 
across all doses of U0126 tested. While the alleles showed varying sensitivities to MEK 
inhibition, none of the animals had the phenotype completely eliminated. In the unstressed assay 
the C. briggsae animals showed a consistent decrease in VPC induction but cell division was 
never eliminated. In the EGF-compromised sur-2 mutants induction was still not able to be 
eliminated even with treatment with U0126. These three assays imply that EGF signaling is 
important for C. briggsae vulva development but also that there must be an additional signaling 
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source that can compensate for EGF when it is compromised. This signaling source may either 
be novel to C. briggsae, or more likely it is a signaling source that is shared among the two 
species but plays a more functionally-important role in C. briggsae than in C. elegans. 
 3) Loss of primary cell fate after U0126 treatment suggests EGF is responsible for vulval 
precursor cells adopting the primary fate. Regardless of how EGF was compromised across the 
three assays (MEK inhibition via U0126 or sur-2 mutants), the C. briggsae P6.p cell conferred a 
secondary cell identity in treated or compromised animals and maintained a primary cell identity 
in untreated wild type animals. With the only changing variable being the level of EGF activity, 
the data suggest that EGF is necessary and sufficient to promote a primary cell identity in a 
vulval precursor cell in C. briggsae vulval development. 
 4) One interpretation of the consistent results in EGF hyperactived, unstressed, and 
compromised systems suggest C. briggsae vulval development may require alternative signaling 
sources other than EGF which may be Notch. When Wnt signaling was compromised using the 
cam-1 reporter there was no observable phenotype either alone or in combination with the U0126 
inhibitor. These data do not support that Wnt signaling accounts for the difference between the 
two species, yet they do not exclude it as a candidate for the difference either. When Notch 
signaling was compromised using the heat shock sel-8 vector the C. briggsae animals showed 
adjacent primary cells in VPCs. It is known that EGF and Notch signaling act antagonistically to 
one another, and the result of adjacent primary VPCs implies that Notch is responsible for 
conferring the secondary cell identity. Further experiments can be done to see if vulval induction 
is completely eliminated in C. briggsae when both EGF and Notch are compromised. 
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